Recently, Tyrnagi International Limited has been successively granted seven overseas patents within one month, including five European patents, one US patent and one Japanese patent. The titles and publication numbers of the seven patents are as follows:

Invention Title: Plasminogen for use in treating diabetes European Patent Publication No.: EP3556392B1 Invention Title: Plasminogen for use in treating radiation and chemical damage European Patent Publication No.: EP3391896B1 Invention Title: Plasminogen for use in treating diabetes European Patent Publication No.: EP3556384B1 Invention Title: Plasminogen for use in treating diabetes European Patent Publication No.: EP3556383B1 Invention Title: Plasminogen for use in treating diabetes European Patent Publication No.: EP3556390B1 Invention Title: Method for regulating and controlling GLP-1/GLP-1R and drug US Patent Publication No.: US11938172B2 Invention Title: 筋萎縮性側索硬化症を治療するための方法と薬剤 Japanese Patent Publication No.: JP7455457B2 Beijing Caihe Law Firm and Beijing Tangsong Yongxin Intellectual Property Agency Co., Ltd. were entrusted by Tyrnagi International Limited to provide patent legal counsel services throughout the above overseas patent applications.